Drug intelligence / Profile preview

DUJOINT TZ

Development stage: Unknown
Lead developer: Wonne International
Modality: Peptides
Administration: Injection

Overview

DUJOINT TZ is an injectable collagen peptide supplement marketed by Wonne International for the support of joints and connective tissues. It is formulated to provide bioactive collagen peptides, which serve as structural components for the repair and maintenance of the extracellular matrix in cartilage and tendons. The product is part of Wonne International's commercial portfolio in India, distributed via a PCD (Propaganda Cum Distribution) pharma franchise model, and is intended to improve joint health and mobility by supplying the necessary amino acid building blocks for connective tissue integrity.

Brand names: DUJOINT TZ Shots
Other names: collagen peptide

Beyond the preview

Go deeper on DUJOINT TZ.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DUJOINT TZ.

Explore the full profile